Prestige Consumer Healthcare (PBH) Competitors

Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, community ranking, dividends and valuation.

Which has higher earnings & valuation, IPAR or PBH?

Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inter Parfums	$1.32B	3.37	$152.65M	$4.66	29.74
Prestige Consumer Healthcare	$1.13B	3.45	$209.34M	$4.11	19.12

Does the MarketBeat Community prefer IPAR or PBH?

Prestige Consumer Healthcare received 28 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.34% of users gave Prestige Consumer Healthcare an outperform vote while only 64.85% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Inter Parfums	Outperform Votes 463 64.85%	Underperform Votes 251 35.15%
Prestige Consumer Healthcare	Outperform Votes 491 70.34%	Underperform Votes 207 29.66%

Do analysts prefer IPAR or PBH?

Inter Parfums currently has a consensus price target of $159.40, suggesting a potential upside of 15.02%. Prestige Consumer Healthcare has a consensus price target of $85.25, suggesting a potential upside of 8.49%. Given Inter Parfums' stronger consensus rating and higher possible upside, research analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prestige Consumer Healthcare	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Do institutionals and insiders believe in IPAR or PBH?

55.6% of Inter Parfums shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 43.9% of Inter Parfums shares are held by company insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media refer more to IPAR or PBH?

In the previous week, Prestige Consumer Healthcare had 1 more articles in the media than Inter Parfums. MarketBeat recorded 8 mentions for Prestige Consumer Healthcare and 7 mentions for Inter Parfums. Inter Parfums' average media sentiment score of 0.89 beat Prestige Consumer Healthcare's score of 0.64 indicating that Inter Parfums is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inter Parfums	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is IPAR or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 18.54% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inter Parfums	10.60%	16.34%	10.82%
Prestige Consumer Healthcare	18.54%	12.23%	6.14%

Which has more risk & volatility, IPAR or PBH?

Inter Parfums has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500.

Summary

Inter Parfums beats Prestige Consumer Healthcare on 11 of the 18 factors compared between the two stocks.